Company says details of “when and how best to bring Auvi-Q back to the market” still being worked out.
Expanded survey looked at more than 6,500 elementary, middle and high schools.
Highly positive results seen for early peanut and egg introduction, but more study needed on other allergens.
Case will now see two sides exchange evidence and attend mandatory mediation.
In a long-term follow-up study, oral immunotherapy (OIT) patients who were treated for up to five food allergies were able to maintain a high level of desensitization to their allergens, even those taking very low “doses” of their allergens.
Many patients with eczema go on to develop food allergies, a phenomenon often referred to as “the allergic march.”
Consumer survey shows many take risks with ‘may contain’ allergen labels.
Study had at-risk children avoid peanuts for 12 months.
Kaléo has yet to determine the future of the Auvi-Q and Allerject auto-injector.
Carrier will be the first major international airline to make this policy change.